✨ Free AI Report
Calithera Biosciences, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Calithera Biosciences, Inc.
Research Preview

Calithera Biosciences, Inc.: Business Overview, Financials & Competitive Analysis

Calithera Biosciences operates under a plan of liquidation approved in January 2023 and was previously engaged in clinical stage precision oncology biopharmaceutical business. The company is winding up its operations ...

Analyst-debate audio for Calithera Biosciences, Inc.

AskCyborg analysts argue the bull and bear cases for Calithera Biosciences, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Calithera Biosciences, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
2/ 10Challenged

Cyborg Score thesis

Shell company in advanced liquidation with negligible investor appeal; primarily of interest only for asset sale potential or...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals (Liquidated/Shell Company Status)
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Calithera Biosciences, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Calithera Biosciences, Inc. Overview

Pro stress-test →

Calithera Biosciences operates under a plan of liquidation approved in January 2023 and was previously engaged in clinical stage precision oncology biopharmaceutical business. The company is winding up its operations and seeking to sell all of its clinical assets and programs.

Strategic Profile

Pro stress-test →

The company was focused on discovery and development of small molecule inhibitors targeting metabolic pathways critical to cancer cell growth, aiming to create novel therapeutic options for solid tumors and hematologic malignancies. The company has not generated any revenue.

Competitive Landscape

Pro stress-test →

Company is no longer a competitive participant in the oncology metabolic pathway inhibitor space. Historical competitors included other precision oncology firms developing tumor metabolism-targeting therapies, but Calithera has exited the competitive market through liquidation.

Industry Context

Calithera Biosciences, Inc. operates in Biopharmaceuticals (Liquidated/Shell Company Status).

Key facts

Founded: 2010 · Headquarters: South San Francisco, California · Revenue: $0 · Market cap: $974

What the analysts stress-tested

The top findings that survived the multi-agent debate for Calithera Biosciences, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Calithera Biosciences, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Precision oncology platformsCompeting metabolic pathway inhibitor development (historical context only)→

Compare Calithera Biosciences, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Calithera Biosciences, Inc. operates in Biopharmaceuticals (Liquidated/Shell Company Status). See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals (Liquidated/Shell Company Status) research →
NEW · MCP server

Ask your AI assistant about Calithera Biosciences, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Calithera Biosciences, Inc. and its top competitor on Cyborg Score”
“What did Calithera Biosciences, Inc. do this quarter?”
“Is Calithera Biosciences, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Calithera Biosciences, Inc. do?+
Calithera Biosciences operates under a plan of liquidation approved in January 2023 and was previously engaged in clinical stage precision oncology biopharmaceutical business. The company is winding up its operations ...
What is Calithera Biosciences, Inc.'s Cyborg Score?+
Calithera Biosciences, Inc. has a Cyborg Score of 2/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Calithera Biosciences, Inc.'s main competitors?+
Named competitors include Precision oncology platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full Calithera Biosciences, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Calithera Biosciences, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Calithera Biosciences, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.